S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

Sanofi SEC Filings & 10K Form (NYSE:SNY)

$45.62
-0.43 (-0.93 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
$45.53
Now: $45.62
$45.94
50-Day Range
$44.34
MA: $45.81
$47.20
52-Week Range
$40.00
Now: $45.62
$47.47
Volume805,938 shs
Average Volume1.30 million shs
Market Capitalization$114.24 billion
P/E Ratio14.58
Dividend Yield2.52%
Beta0.67

SEC Filings

Sanofi (NYSE:SNY) SEC Filings

DateFilerForm TypeView
10/31/2019
12:14 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2019
5:48 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2019
12:43 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2019
4:00 PM
REGENERON PHARMACEUTICALS, INC. (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
5:35 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2019
7:22 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2019
3:30 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2019
9:41 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2019
9:13 AM
Fulcrum Therapeutics, Inc. (Subject)
Sanofi (Filed by)
Form SC 13G
07/26/2019
5:16 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2019
10:39 AM
Fulcrum Therapeutics, Inc. (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
6:30 PM
Fulcrum Therapeutics, Inc. (Issuer)
Sanofi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/16/2019
9:29 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2019
1:56 PM
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/28/2019
1:51 PM
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/18/2019
7:44 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/07/2019
5:39 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2019
8:14 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2019
5:10 AM
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
05/03/2019
3:02 PM
ALNYLAM PHARMACEUTICALS, INC. (Subject)
Sanofi (Filed by)
Form SC 13G/A
04/29/2019
9:57 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2019
9:15 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2019
7:19 PM
REGENERON PHARMACEUTICALS INC (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
1:35 PM
Sanofi (Filer)
Form IRANNOTICE
03/08/2019
1:30 PM
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/26/2019
6:41 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2019
5:12 AM
MyoKardia Inc (Subject)
Sanofi (Filed by)
Form SC 13G/A
02/15/2019
5:05 AM
MyoKardia Inc (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2019
12:14 PM
Sanofi (Filed by)
SCYNEXIS INC (Subject)
Form SC 13G/A
02/11/2019
10:06 AM
BlackRock Inc. (Filed by)
Sanofi (Subject)
Form SC 13G/A
02/11/2019
7:41 AM
Sanofi (Filed by)
Voyager Therapeutics, Inc. (Subject)
Form SC 13G/A
02/11/2019
7:37 AM
MyoKardia Inc (Subject)
Sanofi (Filed by)
Form SC 13G/A
02/11/2019
7:33 AM
Sanofi (Filed by)
Unum Therapeutics Inc. (Subject)
Form SC 13G
02/07/2019
1:52 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2019
7:53 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2019
2:13 PM
ALNYLAM PHARMACEUTICALS, INC. (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
8:07 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2018
10:27 AM
Sanofi (Filer)
Form CERT
12/31/2018
5:25 AM
Sanofi (Filer)
Form 8-A12B
12/31/2018
5:20 AM
Sanofi (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
12/18/2018
3:47 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2018
5:20 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2018
7:24 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2018
2:30 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2018
7:58 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2018
2:14 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/14/2018
8:33 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2018
4:01 PM
REGENERON PHARMACEUTICALS INC (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
7:46 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2018
12:25 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2018
8:40 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/26/2018
7:27 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2018
6:43 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2018
8:05 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2018
5:12 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/19/2018
1:15 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/19/2018
5:38 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC 13D/A
06/19/2018
5:34 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
06/14/2018
2:36 PM
Sanofi (Filer)
Form 424B5
06/13/2018
10:13 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2018
4:30 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
06/12/2018
7:30 AM
Sanofi (Filer)
Form 424B5
06/12/2018
7:21 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/11/2018
5:52 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/08/2018
1:08 PM
Sanofi (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/07/2018
6:26 AM
Sanofi (Filer)
Form 6-K/A
06/05/2018
10:06 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2018
5:36 AM
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
05/29/2018
3:34 PM
MyoKardia Inc (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
5:39 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC 13D
05/22/2018
8:29 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/18/2018
3:32 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
05/15/2018
7:44 AM
Sanofi (Filer)
Form S-8 POS
05/14/2018
7:02 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
05/07/2018
7:14 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
05/03/2018
8:23 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/27/2018
1:28 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2018
9:13 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2018
5:12 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2018
6:50 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T
04/03/2018
7:15 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/29/2018
1:13 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-C
03/29/2018
8:51 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/16/2018
6:55 AM
Sanofi (Filer)
Form 20-F/A
03/15/2018
10:10 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2018
10:28 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/08/2018
12:14 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/08/2018
7:04 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/08/2018
5:10 AM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-T/A
03/07/2018
12:57 PM
Sanofi (Filer)
Form IRANNOTICE
03/07/2018
12:39 PM
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/06/2018
2:16 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/02/2018
8:02 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/01/2018
2:01 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-C
02/23/2018
3:03 PM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-T/A
02/20/2018
4:31 PM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-T/A
02/20/2018
1:47 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-C
02/13/2018
3:58 PM
Regulus Therapeutics Inc. (Subject)
Sanofi (Filed by)
Form SC 13G/A
02/13/2018
3:55 PM
ALNYLAM PHARMACEUTICALS, INC. (Subject)
Sanofi (Filed by)
Form SC 13G/A
02/13/2018
3:55 PM
MyoKardia Inc (Subject)
Sanofi (Filed by)
Form SC 13G/A
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel